Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjogren's syndrome

Laboratory Investigation

Volumn 79, Issue 3, 1999, Pages 261-269

  Nakamura, Hideki ^a   Kawakami, Atsushi ^a   Tominaga, Masahiro ^a   Migita, Kiyoshi ^a   Kawabe, Yojiro ^a   Nakamura, Tatsufumi ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN BCL 2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME;

AGED; ANTIGENS, CD; ANTIGENS, CD40; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOOD CELLS; CD40 LIGAND; FEMALE; HTLV-I ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 0032922059     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993). bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
2. Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM (1997). Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death. J Immunol 159:3156-3167.
3. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK (1996). Hyperexpression of CD40 ligand by B and T Cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97:2063-2073.
4. Early GS, Zhao W, Burns CM (1996). Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. J Immunol 157:3159-3164.
5. Eguchi K, Matsuoka N, Ida H, Nakashima M, Sakai M, Sakito S, Kawakami A, Terada K, Shimada H, Kawabe Y, Fukuda T, Sawada T, Nagataki S (1992). Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51:769-776.
6. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJA, Claassen E (1996). CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 93:2499-2504.
7. Gray D, Dullforce P, Jainandunsing S (1994). Memory B cell development but not germinal center formation is impaired by in vitro blockade of CD40-CD40 ligand interaction. J Exp Med 180:141-155.
8. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissort B, Segarra C, Bologna C, Bourrat L, Combe B, Blanc F, Sany J (1996). Sicca syndrome associated with hepatitis C infection. Arthritis Rheum 39:1166-1171.
9. Kong L, Ogawa N, Nakabayashi T, Liu GT, D'souza E, McGuff HS, Guerrero D, Talal N, and Dang H (1997). Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 40:87-97.
10. Koshy M, Berger D, Crow MK (1996). Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98:826-837.
11. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M (1995). CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154:97-102.
12. Mohan C, Shi Y, Laman JD, Datta SK (1995). Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480.
13. Moutsopoulos HM, Chused TM, Mann DL, Rlippel JH, Fauci AS, Frank MM, Lawley TJ, Hamburger MI (1980). Sjögren's syndrome (sicca syndrome) current issues. Ann Intern Med 92:212-226.
14. Nakamura H, Eguchi K, Nakamura T, Mizokami A, Shirabe S, Kawakami A, Matsuoka N, Migita K, Kawabe Y, Nagataki S (1997). High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56:167-172.
15. Nakamura H, Koji T, Tominaga M, Kawakami A, Migita K, Kawabe Y, Nakamura T, Shirabe S, Eguchi K (1998). Apoptosis in labial salivary glands from Sjögren's syndrome patients-comparison with the HTLV-I-seronegative and -seropositive Sjögren's syndrome patients. Clin Exp Immunol 114:106-112.
16. Nakao H, Eguchi K, Kawakami A, Migita K, Otsubo T, Ueki Y, Shimomura C, Tezuka H, Matsunaga M, Maeda K, Nagataki S (1990). Phenotypic characterization of lymphocytes infiltrating synovial tissue from patients with rheumatoid arthritis: analysis of lymphocytes isolated from minced synovial tissue by dual immunofluorescent staining. J Rheum 17:142-148.
17. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD (1993). B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 178:1097-1102.
18. Oltvai ZN, Milliman CL, Korsmeyer (1993). Bcl-2 heterodimerized in vitro with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
19. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A (1987). Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T cell leukemia-like cells. Ann Neurol 21:117-122.
20. Osamura RY, Watanabe K, Nakai Y, Imura H (1980). Adrenocorticotropic hormone cells and immunoreactive b-endorphin cells in the human pituitary gland. Am J Pathol 99:105-124.
21. Pease CT, Charles PJ, Shattles W, Markwick J, Maini RN. Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome (1993). Br J Rheumatol 32:574-577.
22. Saito I, Shimuta M, Terauchi K, Tsubota K, Yodoi J, Miyasaka N (1996). Increased expression of human thioredoxin/adult T cell leukemia-derived factor in Sjögren's syndrome. Arthritis Rheum 39:773-782.
23. Stout RD and Suttles J (1996). The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17: 487-492.
24. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S, Miyamoto T (1994). Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 344:1116-1119.
25. Tsubata T, Wu J, Honjo T (1993). B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364:645-648.
26. van Essen D, Kikutani H, Gray D (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620-623.
27. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, Vita S, Drosos AA, Ehrenfeld M, Hatron PY, Hay EM, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec Y, Prause JU, Richards A, Sauvezie B, Schiødt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, Youinou P (1993). Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by European Community. Arthritis Rheum 36:340-347.
28. Xu KP, Katagiri S, Takeuchi T, Tsubota K (1996). Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome. J Rheumatol 2:76-82.